A-Series BiPAP Hybrid A30 (not marketed in US), A-Series… recallZ-1957-2021 · Philips Respironics, Inc. · initiated Jun 14, 2021
Class I Open, Classified All recalls posted in July 2021
Is my device affected?
- Compare the model, catalog and lot or serial numbers on your device or its packaging with the code information below. A recall usually covers only specific models or lots.
- If yours is listed, follow the instructions from Philips Respironics, Inc. or your healthcare provider. The company's action is summarized under what the company is doing.
- Do not stop using a prescribed or implanted device on your own — talk to your healthcare provider first.
Where to find your model and lot numbers · What recall classes and statuses mean
Why it was recalled
The polyester-based polyurethane (PE-PUR) foam may degrade into particles which may enter the devices air pathway and be ingested or inhaled by the user, and the PE-PUR foam may off-gas certain chemicals.
FDA root cause category: Device Design
What the company is doing
Urgent Medical Device Recall letters were sent to customers starting 6/14/21. 1. Do not stop or alter your prescribed therapy until you have talked to your physician. Your physician may evaluate if the benefit outweighs the risks. 2. If your physician determines that you must continue using this device, use an inline bacterial filter. Your Instructions for Use has guidance on installation. 3. Register your device on www.philips.com/src-update or call 1-877-907-7508. An updated URGENT: Medical Device Recall notification letter was issued on 11/16/21. 1. Do not stop or change ventilator use until you have talked to your health care provider. If patients requiring a ventilator for life-sustaining therapy have no alternate, or therapy disruption is unacceptable, the HCP may determine if the benefit of continued use of these ventilator devices outweighs the potential risks identified in the recall letter. 2. Talk to your HCP about using an inline bacterial filter to help filter out foam particles. Instructions for Use has guidance on installation. At this time, the FDA does not have evidence of the safety and effectiveness of a filter for mitigating the foam risks, and evaluation is ongoing. Filters will not reduce exposure to chemicals from the PE-PUR foam. Filters may increase air flow resistance and affect ventilator performance. Monitor for accumulation of foam debris in the filter or resistance-related problems in the breathing circuit after filter placement. 3. Report any problems with a device through the FDA MedWatch Voluntary Reporting Form. 4. Register your device on the recall website www.philips.com/src-update with your device Serial Number, or call 1-877-907-7508. Devices should be serviced only by qualified technicians. There are no user serviceable parts. Attempts to remove the sound abatement foam may render the device permanently inoperative. Devices damaged due to foam removal attempts will not be able to be remediated.
Recall details
- Recall number
- Z-1957-2021
- Recall class
- Class I (most serious)
- Status
- Open, Classified
- Initiated by the company
- Jun 14, 2021
- Posted by the FDA
- Jul 15, 2021
- Recalling firm
- Philips Respironics, Inc.
- Quantity
- 8047
- Product code
- MNS
- FDA submissions
- K113053
- Distribution
- Worldwide distribution including US Nationwide, Argentina, Australia, Brazil, Canada, China, France, Germany, Italy, Japan, Korea, and Latin America.
Product description
A-Series BiPAP Hybrid A30 (not marketed in US), A-Series BiPAP V30 Auto Continuous Ventilator, Minimum Ventilatory Support, Facility Use
Code information (models, lots, serial numbers)
All Devices manufactured before 26 April 2021, All device serial numbers. Material Numbers 1111181 1111182 1111178 1140184 1135427 1143671
Other devices under the same FDA submission
22 devices cleared under K113053 — the recall does not name any of them by identifier. One submission often covers many models, so they may or may not be affected.
- BiPAP A30 00Respironics, Inc. · VENTILATOR, CONTINUOUS, NON-LIFE-SUPPORTING2 recalls29 reports
- BiPAP A30 BiPAP A30 Ventilator, INTLRespironics, Inc. · VENTILATOR, CONTINUOUS, NON-LIFE-SUPPORTING2 recalls1 death17 reports
- BiPAP A30 BiPAP A30 Ventilator, FRRespironics, Inc. · VENTILATOR, CONTINUOUS, NON-LIFE-SUPPORTING1 recall52 reports
- BiPAP A30 BiPAP A30 Silver Series Ventilator, DERespironics, Inc. · VENTILATOR, CONTINUOUS, NON-LIFE-SUPPORTING1 recall28 reports
- BiPAP A30 BiPAP A30-S Silver Series VentilatorRespironics, Inc. · VENTILATOR, CONTINUOUS, NON-LIFE-SUPPORTING1 recall18 reports
- BiPAP A30 00Respironics, Inc. · VENTILATOR, CONTINUOUS, NON-LIFE-SUPPORTING1 recall18 reports
- BiPAP A30 BiPAP A30 Ventilator Private Label, INTLRespironics, Inc. · VENTILATOR, CONTINUOUS, NON-LIFE-SUPPORTING1 recall13 reports
- BiPAP V30 Auto BiPAP V30 Auto, USRespironics, Inc. · VENTILATOR, CONTINUOUS, NON-LIFE-SUPPORTING1 recall6 reports
- BiPAP A30 00Respironics, Inc. · VENTILATOR, CONTINUOUS, NON-LIFE-SUPPORTING1 recall4 reports
- BiPAP A30 BiPAP A30 Ventilator w/H Tube Humid, CARespironics, Inc. · VENTILATOR, CONTINUOUS, NON-LIFE-SUPPORTING1 recall3 reports
- BiPAP V30 Auto 00Respironics, Inc. · VENTILATOR, CONTINUOUS, NON-LIFE-SUPPORTING1 recall2 reports
- BiPAP A30 BiPAP A30 Ventilator, AURespironics, Inc. · VENTILATOR, CONTINUOUS, NON-LIFE-SUPPORTING1 recall0 reports
Other products in the same recall event
The FDA groups related products into one recall event (event 88071).
- Z-1956-2021 · Open, ClassifiedTrilogy 100, Trilogy 200, Garbin Plus, Aeris, LifeVent Continuous Ventilators.
- Z-1958-2021 · Open, ClassifiedA-Series BiPAP A 40, A-Series BiPAP A30 Continuous Ventilator, Non-life Supporting
Sources and updates
- Recall record: FDA Medical Device Recalls, file dated Oct 16, 2026 · View the FDA recall notice ↗
- Devices: FDA GUDID, file dated Oct 13, 2026. Devices are linked when their identifier (with a valid check digit) appears in the recall's code information.
- Page last rebuilt: Oct 18, 2026. Text above is shown as published by the FDA.
How recalls are matched to devices · Editorial policy · Report an error on this page